Quest PharmaTech Inc. QPT.V Stock
Quest PharmaTech Inc. Price Chart
Quest PharmaTech Inc. QPT.V Financial and Trading Overview
| Quest PharmaTech Inc. stock price | 0.03 CAD |
| Previous Close | 0.09 CAD |
| Open | 0.09 CAD |
| Bid | 0.09 CAD x 0 |
| Ask | 0.1 CAD x 0 |
| Day's Range | 0.09 - 0.09 CAD |
| 52 Week Range | 0.05 - 0.12 CAD |
| Volume | 15.5K CAD |
| Avg. Volume | 9.95K CAD |
| Market Cap | 15.22M CAD |
| Beta (5Y Monthly) | 0.805194 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | July 21, 2005 |
| 1y Target Est | N/A |
QPT.V Valuation Measures
| Enterprise Value | 15.85M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.18292683 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -19.308 |
Trading Information
Quest PharmaTech Inc. Stock Price History
| Beta (5Y Monthly) | 0.805194 |
| 52-Week Change | -10.0000024% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.12 CAD |
| 52 Week Low | 0.05 CAD |
| 50-Day Moving Average | 0.09 CAD |
| 200-Day Moving Average | 0.08 CAD |
QPT.V Share Statistics
| Avg. Volume (3 month) | 9.95K CAD |
| Avg. Daily Volume (10-Days) | 5K CAD |
| Shares Outstanding | 169.13M |
| Float | 163.1M |
| Short Ratio | 2.22 |
| % Held by Insiders | 16.82% |
| % Held by Institutions | 0% |
| Shares Short | 13K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.010% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | January 31, 2023 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | January 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -0.59% |
| Return on Equity (ttm) | -8.44% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -820730 CAD |
| Net Income Avi to Common (ttm) | -7332315 CAD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 374.66K CAD |
| Total Cash Per Share (mrq) | 0.002 CAD |
| Total Debt (mrq) | 1M CAD |
| Total Debt/Equity (mrq) | 1.2 CAD |
| Current Ratio (mrq) | 0.562 |
| Book Value Per Share (mrq) | 0.492 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -554683 CAD |
| Levered Free Cash Flow (ttm) | -593252 CAD |
Profile of Quest PharmaTech Inc.
| Country | Canada |
| State | AB |
| City | Edmonton |
| Address | 4342 - 97 street NW |
| ZIP | T6E 5R9 |
| Phone | N/A |
| Website | https://www.questpharmatech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.
Q&A For Quest PharmaTech Inc. Stock
What is a current QPT.V stock price?
Quest PharmaTech Inc. QPT.V stock price today per share is 0.03 CAD.
How to purchase Quest PharmaTech Inc. stock?
You can buy QPT.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Quest PharmaTech Inc.?
The stock symbol or ticker of Quest PharmaTech Inc. is QPT.V.
Which industry does the Quest PharmaTech Inc. company belong to?
The Quest PharmaTech Inc. industry is Biotechnology.
How many shares does Quest PharmaTech Inc. have in circulation?
The max supply of Quest PharmaTech Inc. shares is 169.13M.
What is Quest PharmaTech Inc. Price to Earnings Ratio (PE Ratio)?
Quest PharmaTech Inc. PE Ratio is now.
What was Quest PharmaTech Inc. earnings per share over the trailing 12 months (TTM)?
Quest PharmaTech Inc. EPS is -0.12 CAD over the trailing 12 months.
Which sector does the Quest PharmaTech Inc. company belong to?
The Quest PharmaTech Inc. sector is Healthcare.